Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association
Authors
Keywords
-
Journal
CIRCULATION
Volume 140, Issue 12, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2019-08-19
DOI
10.1161/cir.0000000000000709
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
- (2019) Scott M. Grundy et al. CIRCULATION
- Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial
- (2018) Stephen J. Nicholls et al. CLINICAL CARDIOLOGY
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of MAT9001 containing eicosapentaenoic acid and docosapentaenoic acid, compared to eicosapentaenoic acid ethyl esters, on triglycerides, lipoprotein cholesterol, and related variables
- (2017) Kevin C. Maki et al. Journal of Clinical Lipidology
- Prescription omega-3 fatty acid products containing highly purified eicosapentaenoic acid (EPA)
- (2017) Eliot A. Brinton et al. Lipids in Health and Disease
- Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
- (2017) Frederick E. Dewey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Omega-3 Fatty Acid Formulations in Cardiovascular Disease: Dietary Supplements are Not Substitutes for Prescription Products
- (2016) Jonathan Fialkow American Journal of Cardiovascular Drugs
- A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (ComparED) Study
- (2016) Janie Allaire et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention
- (2016) Sarabjeet Singh et al. AMERICAN JOURNAL OF THERAPEUTICS
- Vascular and metabolic effects of omega-3 fatty acids combined with fenofibrate in patients with hypertriglyceridemia
- (2016) Kwang Kon Koh et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Triglyceride-lowering therapies reduce cardiovascular disease event risk in subjects with hypertriglyceridemia
- (2016) Kevin C. Maki et al. Journal of Clinical Lipidology
- Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Australian and New Zealand Fish Oil Products in 2016 Meet Label Omega-3 Claims and Are Not Oxidized
- (2016) Peter Nichols et al. Nutrients
- Fish Oils and Bleeding—Where Is the Evidence?
- (2016) William S. Harris JAMA Internal Medicine
- Dose-response effects of marine omega-3 fatty acids on apolipoproteins, apolipoprotein-defined lipoprotein subclasses, and Lp-PLA2 in individuals with moderate hypertriglyceridemia
- (2015) Ann C. Skulas-Ray et al. Journal of Clinical Lipidology
- Effects of icosapent ethyl on lipoprotein particle concentration and size in statin-treated patients with persistent high triglycerides (the ANCHOR Study)
- (2015) Christie M. Ballantyne et al. Journal of Clinical Lipidology
- National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
- (2015) Terry A. Jacobson et al. Journal of Clinical Lipidology
- Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial
- (2015) Richard L. Dunbar et al. Lipids in Health and Disease
- Effects of Omega-3 Fatty Acid Supplementation on Glucose Control and Lipid Levels in Type 2 Diabetes: A Meta-Analysis
- (2015) Cai Chen et al. PLoS One
- Short Communication: Effects of Omega-3 Fatty Acids on Triglycerides and High-Density Lipoprotein Subprofiles in HIV-Infected Persons with Hypertriglyceridemia
- (2014) Anu Paranandi et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- n-3 Fatty acids affect haemostasis but do not increase the risk of bleeding: clinical observations and mechanistic insights
- (2014) John K. Wachira et al. BRITISH JOURNAL OF NUTRITION
- Using High-Dose Omega-3 Fatty Acid Supplements to Lower Triglyceride Levels in 10- to 19-Year-Olds
- (2014) Sarah D. de Ferranti et al. CLINICAL PEDIATRICS
- Omega-3 fatty acid therapy dose-dependently and significantly decreased triglycerides and improved flow-mediated dilation, however, did not significantly improve insulin sensitivity in patients with hypertriglyceridemia
- (2014) Pyung Chun Oh et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- A Double-Blind Randomized Trial of Fish Oil to Lower Triglycerides and Improve Cardiometabolic Risk in Adolescents
- (2014) Samuel S. Gidding et al. JOURNAL OF PEDIATRICS
- A comparison of actual versus stated label amounts of EPA and DHA in commercial omega-3 dietary supplements in the United States
- (2014) Alison C Kleiner et al. JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
- Triglycerides and cardiovascular disease
- (2014) Børge G Nordestgaard et al. LANCET
- n-3 PUFA Esterified to Glycerol or as Ethyl Esters Reduce Non-Fasting Plasma Triacylglycerol in Subjects with Hypertriglyceridemia: A Randomized Trial
- (2014) Anne Hedengran et al. LIPIDS
- Efficacy of a unique omega-3 formulation on the correction of nutritional deficiency and its effects on cardiovascular disease risk factors in a randomized controlled VASCAZEN® REVEAL Trial
- (2014) Nisar A. Shaikh et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
- (2014) Anders Berg Jørgensen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Overview of Prescription Omega-3 Fatty Acid Products for Hypertriglyceridemia
- (2014) Howard S. Weintraub POSTGRADUATE MEDICINE
- A new, microalgal DHA- and EPA-containing oil lowers triacylglycerols in adults with mild-to-moderate hypertriglyceridemia
- (2014) Kevin C. Maki et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia
- (2013) Scott M. Grundy et al. ATHEROSCLEROSIS
- Replacement of Reduced Highly Unsaturated Fatty Acids (HUFA Deficiency) in Dilative Heart Failure: Dosage of EPA/DHA and Variability of Adverse Peroxides and Aldehydes in Dietary Supplement Fish Oils
- (2013) Thomas P. Rupp et al. CARDIOLOGY
- Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200–500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study
- (2013) Eliot A Brinton et al. Cardiovascular Diabetology
- A Highly Bioavailable Omega-3 Free Fatty Acid Formulation Improves the Cardiovascular Risk Profile in High-Risk, Statin-Treated Patients With Residual Hypertriglyceridemia (the ESPRIT Trial)
- (2013) Kevin C. Maki et al. CLINICAL THERAPEUTICS
- Omega-3 fatty acid therapy reduces triglycerides and interleukin-6 in hypertriglyeridemic HIV patients
- (2013) TS Metkus et al. HIV MEDICINE
- Effect of omega-3 dietary supplements with different oxidation levels in the lipidic profile of women: a randomized controlled trial
- (2013) V. M. García-Hernández et al. INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
- Comparison of a Novel Method vs the Friedewald Equation for Estimating Low-Density Lipoprotein Cholesterol Levels From the Standard Lipid Profile
- (2013) Seth S. Martin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and safety of TAK-085 compared with eicosapentaenoic acid in Japanese subjects with hypertriglyceridemia undergoing lifestyle modification: The omega-3 fatty acids randomized double-blind (ORD) study
- (2013) Ichiro Tatsuno et al. Journal of Clinical Lipidology
- Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial
- (2013) John J.P. Kastelein et al. Journal of Clinical Lipidology
- Docosahexaenoic acid impairs the maturation of very low density lipoproteins in rat hepatic cells
- (2013) Vatsala Maitin et al. JOURNAL OF LIPID RESEARCH
- Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study)
- (2012) Christie M. Ballantyne et al. AMERICAN JOURNAL OF CARDIOLOGY
- A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: The ECLIPSE (Epanova® compared to Lovaza® in a pharmacokinetic single-dose evaluation) study
- (2012) Michael H. Davidson et al. Journal of Clinical Lipidology
- Effects of prescription niacin and omega-3 fatty acids on lipids and vascular function in metabolic syndrome: a randomized controlled trial
- (2012) Gregory C. Shearer et al. JOURNAL OF LIPID RESEARCH
- (n-3) Fatty Acids and Cardiovascular Health: Are Effects of EPA and DHA Shared or Complementary?
- (2012) Dariush Mozaffarian et al. JOURNAL OF NUTRITION
- Quality analysis of commercial fish oil preparations
- (2012) Jenna C Sullivan Ritter et al. JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
- Successful management of extreme hypertriglyceridemia from pegaspargase with omega-3
- (2012) Bruce Bostrom PEDIATRIC BLOOD & CANCER
- Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients With Very High Triglyceride Levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] Trial)
- (2011) Harold E. Bays et al. AMERICAN JOURNAL OF CARDIOLOGY
- Significant differential effects of omega-3 fatty acids and fenofibrate in patients with hypertriglyceridemia
- (2011) Kwang Kon Koh et al. ATHEROSCLEROSIS
- Fish oil — How does it reduce plasma triglycerides?
- (2011) Gregory C. Shearer et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Oxidised fish oil does not influence established markers of oxidative stress in healthy human subjects: a randomised controlled trial
- (2011) Inger Ottestad et al. BRITISH JOURNAL OF NUTRITION
- Triglycerides and Cardiovascular Disease
- (2011) Michael Miller et al. CIRCULATION
- Omega-3 polyunsaturated fatty acid and insulin sensitivity: A meta-analysis of randomized controlled trials
- (2011) Akintunde O. Akinkuolie et al. CLINICAL NUTRITION
- Effects of Eicosapentaenoic Acid Versus Docosahexaenoic Acid on Serum Lipids: A Systematic Review and Meta-Analysis
- (2011) Melissa Y. Wei et al. Current Atherosclerosis Reports
- Effects of prescription omega-3-acid ethyl esters, coadministered with atorvastatin, on circulating levels of lipoprotein particles, apolipoprotein CIII, and lipoprotein-associated phospholipase A2 mass in men and women with mixed dyslipidemia
- (2011) Kevin C. Maki et al. Journal of Clinical Lipidology
- Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: A review
- (2011) Terry A. Jacobson et al. Journal of Clinical Lipidology
- Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia
- (2010) Ann C Skulas-Ray et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Eicosapentaenoic acid improves hepatic steatosis independent of PPARα activation through inhibition of SREBP-1 maturation in mice
- (2010) Naoki Tanaka et al. BIOCHEMICAL PHARMACOLOGY
- Effects of Prescription Omega-3-Acid Ethyl Esters on Non—High-Density Lipoprotein Cholesterol When Coadministered With Escalating Doses of Atorvastatin
- (2010) Harold E. Bays et al. MAYO CLINIC PROCEEDINGS
- Severe hypertriglyceridemia and pancreatitis: presentation and management
- (2009) Nils Ewald et al. CURRENT OPINION IN LIPIDOLOGY
- Fish Oil and Fenofibrate for the Treatment of Hypertriglyceridemia in HIV-Infected Subjects on Antiretroviral Therapy
- (2009) John G Gerber et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Prescription Omega-3 Fatty Acid as an Adjunct to Fenofibrate Therapy in Hypertriglyceridemic Subjects
- (2009) Eli M Roth et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Prescription Omega-3-Acid Ethyl Esters for the Treatment of Very High Triglycerides
- (2009) Richard Sadovsky et al. POSTGRADUATE MEDICINE
- Beneficial Effect of Omega-3 Fatty Acids on Sirolimus- or Everolimus-Induced Hypertriglyceridemia in Heart Transplant Recipients
- (2009) Sultan Celik et al. TRANSPLANTATION
- Are fish oil supplements safe in finned fish–allergic patients?
- (2008) Barry J. Mark et al. ALLERGY AND ASTHMA PROCEEDINGS
- Effects of Adding Prescription Omega-3 Acid Ethyl Esters to Simvastatin (20 mg/day) on Lipids and Lipoprotein Particles in Men and Women With Mixed Dyslipidemia
- (2008) Kevin C. Maki et al. AMERICAN JOURNAL OF CARDIOLOGY
- Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)
- (2008) Yasushi Saito et al. ATHEROSCLEROSIS
- Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice
- (2008) Young-Ah Moon et al. JOURNAL OF LIPID RESEARCH
- Presecretory oxidation, aggregation, and autophagic destruction of apoprotein-B: A pathway for late-stage quality control
- (2008) M. Pan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More